Contribution of genetic analysis in screening for MEN1 among patients with sporadic disease and one or more typical manifestation

Annales d'Endocrinologie

Volumn 67, Issue 6, 2006, Pages 581-587

  Odou, M F ^a,d   Cardot Bauters, C ^a,d   Vantyghem, M C ^a,d   Carnaille, B ^a,d   Leteurtre, E ^a,d   Pigny, P ^a,d   Verier Mine, O ^b,d   Desailloud, R ^c,d   Porchet, N ^a,d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Service d'Endocrinologie   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d GTE Groupe des Tumeurs Endocrines (http: wwwendocrinonet GTE)   (France)

Author keywords

Genetical analysis; MEN 1; Multiple endocrine neoplasia type 1; Sporadic

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE INSERTION SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEOTIDE SEQUENCE; PANCREAS DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING;

EID: 33845946275     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)73010-4     Document Type: Article

References (24)

1. Balogh K, Patocs A, Majnik J et al. Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene. J Hum Genet 2004 ; 49 : 380-6.
2. Basset JHD, Forbes SA, Pannett AAJ et al. Characterization of mutations in patients with Multiple Endocrine Neoplasia type 1. Am J Hum Genet 1998 ; 62 : 232- 44.
3. Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86 : 5658-71.
4. Calender A, Zhang Chang X, Porchet N, Gaudray P. Genetic abnormalities in multiple neoplasia type 1. in: Surgical Endocrinology : Gerard Doherty Btitt Skögserd, éd. Lippincott Williams & Wilkins, 2001, pp479-94.
5. Cardinal JW, Bergman L, Hayward N et al. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. J Med Genet 2005 ; 42 : 69-74.
6. Carty SE, Helm AK, Amico JA et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surg 1998 ; 124 : 1106-13.
7. Chandrasekharappa S, Guru S, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 ; 276 : 404-7.
8. Crépin M, Escande F, Pigny P et al. Efficient mutation in MEN1 gene using a combination of single-strand conformational polymorphism (MDGA™) and heteroduplex analysis. Electrophoresis 2003; 24 : 26-33.
9. Crépin M, Pigny P, Escande F et al. Evaluation of Denaturing High Performance Liquid Chromatography for the mutational analysis of the MEN1 gene. J Mol Endocrinol 2006; 36 : 369-76.
10. Ellard S, Hattersley AT, Brewer CM, Vaidya B. Detection of a MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol 2005 ; 62 : 169-75.
11. Groupe des Tumeurs Endocrines (GTE) Livret de recommandation sur la Néoplasie Endocrinienne Multiple de type 1 (NEM1), OMIM 131100. 2004 ; 1-24 (http://www.endocrino.net/GTE).
12. Klein RD, Salih S, Bessoni J, Bale AE. Clinical testing for Multiple Endocrine Neoplasia type 1 in a DNA diagnostic laboratory. Genet Med 2005 ; 7 : 131-8.
13. Langer P, Wild A, Hall A, Celik I, Rothmund M, Bartsch DK. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg 2003 ; 90 : 1599- 603.
14. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988 ; 332 : 85.
15. Marx SJ, Agarwal SK, Kester MB et al. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res 1999 ; 54 : 397-438.
16. Marx SJ. Molecular genetics of Multiple endocrine Neoplasia types 1 and 2. Nature Rev 2005 ; 5 : 367- 75.
17. Marx SJ. Multiple Endocrine Neoplasia Type 1. in: The metabolic and molecular bases of inherited disease. Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B., Kinzler KW, Vogelstein B. éd. Mc Graw-Hill, 8th ed. 2001 ; 1 :pp 943-65.
18. Poisson A, Zablewska B, Gaudray P. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Letters 2003 ; 189 : 1-10.
19. Porchet N, Odou MF, Cardot-Bauters C et al. Characterization of MEN1 gene deletion by high resolution CGH microarray in a large MEN1 family. J Intern Medecine 2004 ; 255 : 720.
20. Roijers JFM, De Wit MJ, Van der Luijt RB, Ploos van Amstel HK, Höppener JWM, Lips CJM. Criteria for mutation analysis in MEN1-suspected patients: MEN1 case-finding. Eur J Clin Invest 2000 ; 30 : 487-92.
21. Shapiro SE, Cote GC, Lee JE, Gagel FG, Evans DB. The role of genetics in the surgical management of familial endocrinopathy syndromes. J Am Coll Surg 2003 ; 197 : 818-31.
22. The European Consortium On MEN 1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997 ; 6 : 1177-83
23. Wautot V, Vercherat C, Lespinasse J et al. Germline mutation of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mut 2002 ; 20 : 35-47.
24. Warner J, Epstein M, Sweet A et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 2004 ; 41 : 155- 60.